Major clinical trials in cardiovascular therapeutics 1995-2000.pdf

Major clinical trials in cardiovascular therapeutics 1995-2000 PDF

Robert Haïat

HypertensionHypercholesterolemiaVarious interventions in primary and secondary preventionPrevention of atherosclerosis progressionStable angina and silent myocardial ischemiaUnstable angina and non-q-wave myocardial infarctionAcute myocardial infarctionPost-myocardial infarctionCoronary angioplastyArrhythmiasValvular diseaseChronic heart failureHypertrophic cardiomyopathyVenous thromboembolismAortic aneurysms and peripheral arterial diseaseStrokeMain classifications used in cardiovascular disease

Cardiovascular disease remains a leading cause of death, but stakeholders have ... and the factors associated with the success of new therapies in clinical trials. ... We also compared rates of cardiovascular drugs entering clinical trials with ... ... Steyn DW, Gialdini C. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy ... 2Nottingham Clinical Trials Unit, Nottingham Health Science Partners, ... 5. handsearches of 30 journals and the proceedings of major con- ferences; ... Cardiovascular Pharmacology 1987;10(Suppl 3):S101- S103.

8.17 MB Taille du fichier
9782876713802 ISBN
Libre PRIX
Major clinical trials in cardiovascular therapeutics 1995-2000.pdf


PC et Mac

Lisez l'eBook immédiatement après l'avoir téléchargé via "Lire maintenant" dans votre navigateur ou avec le logiciel de lecture gratuit Adobe Digital Editions.

iOS & Android

Pour tablettes et smartphones: notre application de lecture tolino gratuite

eBook Reader

Téléchargez l'eBook directement sur le lecteur dans la boutique ou transférez-le avec le logiciel gratuit Sony READER FOR PC / Mac ou Adobe Digital Editions.


Après la synchronisation automatique, ouvrez le livre électronique sur le lecteur ou transférez-le manuellement sur votre appareil tolino à l'aide du logiciel gratuit Adobe Digital Editions.

Notes actuelles

Sofya Voigtuh

The GABA system is the major inhibitory signaling pathway of the brain and central nervous system (CNS), and contributes significantly to regulating CNS function. SAGE-217 is currently being developed for MDD, PPD and certain other mood disorders. About Sage Therapeutics Sage Therapeutics is a clinical-stage biopharmaceutical company committed to developing novel medicines to transform the Harvard Medical School. ... Al acuñar la expresión «factor de riesgo», el Framingham Heart Study facilitó un ... with increased disease frequency and that is a significant independent predictor of an ... Trends in cardiovascular risk factor prevalence (1995-2000-2005) in ... The therapeutic challenge of systolic hypertension.

Mattio Müllers

Cellular Therapeutics for Heart Failure: Focus on ... Recently, MSCs have been incorporated as the central focus in clinical trials investigating the role how MSCs can play in the treatment of HF. In this review, we focus on the characteristics of MSCs that give them a distinct edge as cellular therapeutics and present results of clinical trials investigating MSCs in the setting of ischemic HF.

Noels Schulzen

Clinical Trials. We are advancing our ADCs through clinical trials in multiple hematological and solid tumor indications, including a pivotal Phase 2 trial of ADCT-402 (loncastuximab tesirine) in patients with relapsed or refractory diffuse large B-cell lymphoma. News. May 14, 2020. ADC Therapeutics Announces Pricing of Upsized Initial Public Offering. READ MORE. May 11, 2020. ADC Therapeutics Cellular Therapeutics for Heart Failure: Focus on ...

Jason Leghmann

Pharmaceutical Research and Manufacturers of America. 2016 biopharmaceutical research ... entities and new therapeutic biological products. ... Cardiovascular Disease: Two new medicines ... and have showed significant clinical impact by. 1 Jan 2005 ... In clinical trials intended to provide the pivotal evidence for regulatory ... positive effect on the clinical outcome of primary interest—sudden cardiac ... drugs provided important therapeutic benefits that they thought it would not be ... trials for eight products that had received AA during 1995–2000—the first five ...

Jessica Kolhmann

Therapeutics. We have extensive experience in a broad range of therapeutic areas. Managing studies in all major geographies, we have established solid working relationships with the world’s leading investigators. Read More